imipenem, anhydrous has been researched along with Myoclonic Jerk in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jones, DP; Kink, RJ; Lau, KK | 1 |
Eidelberg, D; Frucht, S | 1 |
Crespo, M; Marcén, R; Ortuño, J; Rivera, M; Teruel, JL | 1 |
3 other study(ies) available for imipenem, anhydrous and Myoclonic Jerk
Article | Year |
---|---|
Myoclonus associated with intraperitoneal imipenem.
Topics: Anti-Bacterial Agents; Ascitic Fluid; Child, Preschool; Enterobacter cloacae; Enterobacteriaceae Infections; Humans; Imipenem; Infusions, Parenteral; Kidney Failure, Chronic; Male; Medication Errors; Meropenem; Myoclonus; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Thienamycins; Tobramycin | 2004 |
Imipenem-induced myoclonus.
Topics: Adenocarcinoma; Arm; Female; Humans; Imipenem; Middle Aged; Myoclonus; Ovarian Neoplasms; Thienamycins | 1997 |
Neurotoxicity due to imipenem/cilastatin in patients on continuous ambulatory peritoneal dialysis.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Cilastatin; Humans; Imipenem; Kidney Failure, Chronic; Male; Middle Aged; Myoclonus; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Protease Inhibitors; Pruritus; Thienamycins | 1999 |